M&A - CV Sciences, Inc.

Form Type: 10-K

Filing Date: 2025-03-27

Corporate Action: Acquisition

Type: Update

Accession Number: 000095017025046180

Filing Summary: CV Sciences, Inc. has undergone significant developments including the acquisition of Cultured Foods Sp. z.o.o., a leading European manufacturer and distributor of plant-based protein products, in December 2023, making it a wholly owned subsidiary. Additionally, the company has launched a new brand, Lunar Fox™, focused on plant-based products in the U.S. market in January 2025. The company continues to evaluate inbound and outbound merger, sale, acquisition, or other opportunities as part of its strategic financial planning. Furthermore, in May 2024, CV Sciences acquired Elevated Softgels, a manufacturer of encapsulated softgels and tinctures, further expanding its product offerings. The company plans to continue scaling operations and developing cannabinoid-based treatments, although the drug development program is currently dormant. During fiscal year 2024, CV Sciences reported an aggregate market value of approximately $11 million for its common stock held by non-affiliates, with 184,263,663 shares outstanding as of March 24, 2025. The company’s common stock is traded on the OTC:QB market under the symbol CVSI.

Document Link: View Document